March 2023
Includes: Prostate Cancer ADT Increases Bone Fracture Risk, Testosterone Therapy, Improving Survival in Black Patients, Advanced Prostate Cancer on the rise, Cal Ripken Jr. on PC, and more!
THE PATHFINDER AWARD FOR 2025 POSTHUMOUSLY HONOURS PROSTAID CALGARY FOUNDER AND MEMBER RON GORHAM
Includes: Prostate Cancer ADT Increases Bone Fracture Risk, Testosterone Therapy, Improving Survival in Black Patients, Advanced Prostate Cancer on the rise, Cal Ripken Jr. on PC, and more!